R
Rlam
@rlam
Imported Bluesky account. Main topic: general. Original handle: rlam.bsky.social.
0 Following
0 Followers
R
Replying to
@rlam
Hard on patients and pharmacists (already drowning in work). The side effect profile is also ... yeesh. But I also know that people thought they were life changing in a good way and worth it. I think they might be one of our pharmaceutical regrets though
74,500 views
R
Replying to
@estover
One of the things that was the most frustrating, besides the exorbitant cost to patients (even those lucky enough to have insurance), was that they started people on them and there wasn't an adequate supply to maintain them on the doses they were supposed to be on.
74,500 views
R
Replying to
@estover
I only did a brief stint in the last few years as a retail pharmacist, but it was in the time of the GLP-1 agonists. So I am definitely in agreement with you on that. I think there should be more regulation on PhRMA, it has always just felt so powerful.
74,500 views
R
Replying to
@estover
I mean, yes, that's what it has been doing for decades. The FDA is also routinely underfunded for the scope that people expect it to do. Is PhRMA suddenly going to roll over? Also, assume I know a lot about this.
74,500 views
R
Replying to
@ddiamond
PhRMA is pretty powerful. Do they have enough pull to pushback on him?
74,500 views
R